Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Apr 2024 for SANOFI, €91k. Read the official filing
Filing timeline
BuySaleAntoine Yver
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Antoine Yver: trading record in brief
All filings by Antoine Yver on record concern Sanofi, in the capacity of board member. We count 2 filings; the first trade dates from 23 June 2022 and the latest from 26 April 2024.
Every open-market trade on record is a purchase: 2 purchases worth €139k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2024, the count stands at 1 purchase and no sales.
The record was last updated on 30 April 2024 with an open-market purchase (€91k) in Sanofi. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Companies and markets linked to Antoine Yver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,000 shares@ €91.3865.8% of flowActionEuronext ParisISIN FR00001205782024DD963006
Canonical exit: 25 Jul 2024 (T+90)
1,000 shares@ US$50.3434.2% of flowAmerican Depository Receipts (ADR)Nasdaq Global Select MarketISIN FR00001205782022DD848739
Canonical exit: 21 Sept 2022 (T+90)
2 of 2 declarations
